Roche (OTCMKTS:RHHBY) Stock Passes Above 50-Day Moving Average – Time to Sell?

Shares of Roche Holding AG (OTCMKTS:RHHBY) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $52.13 and traded as high as $57.57. Roche shares last traded at $57.26, with a volume of 1,356,317 shares trading hands.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on RHHBY shares. HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a report on Monday, July 6th. Morgan Stanley upgraded shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price objective on the stock in a research note on Friday. Finally, Zacks Research cut Roche from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 14th. Five investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $60.00.

Roche Stock Performance

The stock’s fifty day moving average is $52.13 and its two-hundred day moving average is $52.89. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12.

Hedge Funds Weigh In On Roche

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Verity Asset Management Inc. raised its stake in Roche by 20.9% during the 3rd quarter. Verity Asset Management Inc. now owns 10,990 shares of the company’s stock valued at $459,000 after acquiring an additional 1,898 shares in the last quarter. Hancock Whitney Corp increased its holdings in shares of Roche by 4.8% during the third quarter. Hancock Whitney Corp now owns 24,488 shares of the company’s stock valued at $1,024,000 after purchasing an additional 1,116 shares during the period. Meritage Portfolio Management bought a new stake in shares of Roche during the fourth quarter valued at about $4,372,000. Oakworth Capital Inc. lifted its holdings in Roche by 20.8% in the fourth quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock worth $86,000 after purchasing an additional 285 shares during the period. Finally, HighPoint Advisor Group LLC lifted its holdings in Roche by 55.3% in the fourth quarter. HighPoint Advisor Group LLC now owns 16,515 shares of the company’s stock worth $852,000 after purchasing an additional 5,882 shares during the period.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann?La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.